Quick Answer
Passage BIO, Inc. reported Net Income Loss of -$45.52 million for the year ending 2025.
- Passage BIO, Inc. showed an increase of +29.7% in Net Income Loss from 2024 to 2025.
- This data is from Passage BIO, Inc.'s annual report (Form 10-K), filed with the SEC on March 3, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 7 years of available data (2019 to 2025), Passage BIO, Inc.'s Net Income Loss has grown by 0.2%.
- Historical annual values: Fiscal year 2025: -$45.52 million | Fiscal year 2024: -$64.77 million | Fiscal year 2023: -$102.06 million | Fiscal year 2022: -$136.13 million | Fiscal year 2021: -$185.39 million | Fiscal year 2020: -$112.23 million | Fiscal year 2019: -$45.63 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: